Goldman Sachs: Opko Health OPK Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 12.9 M | Compra |
8,005,331
+969,839
| +14% | +USD 1.41 M | ﹤0.01% | 2989 |
|
|
2026
Q2 | USD 10.6 M | Venta |
7,035,492
-639,534
| -8% | -USD 816 k | ﹤0.01% | 3184 |
|
|
2026
Q1 | USD 8.75 M | Compra |
7,675,026
+1,688,113
| +28% | +USD 2.08 M | ﹤0.01% | 3175 |
|
|
2025
Q4 | USD 7.54 M | Compra |
5,986,913
+3,600,378
| +151% | +USD 5.01 M | ﹤0.01% | 3357 |
|
|
2025
Q3 | USD 3.7 M | Venta |
2,386,535
-433,520
| -15% | -USD 595 k | ﹤0.01% | 3923 |
|
|
2025
Q2 | USD 3.72 M | Venta |
2,820,055
-1,181,159
| -30% | -USD 1.61 M | ﹤0.01% | 3690 |
|
|
2025
Q1 | USD 6.64 M | Compra |
4,001,214
+161,394
| +4% | +USD 266 k | ﹤0.01% | 3078 |
|
|
2024
Q4 | USD 5.64 M | Compra |
3,839,820
+1,097,515
| +40% | +USD 1.68 M | ﹤0.01% | 3330 |
|
|
2024
Q3 | USD 4.09 M | Venta |
2,742,305
-356,017
| -11% | -USD 528 k | ﹤0.01% | 3524 |
|
|
2024
Q2 | USD 3.87 M | Venta |
3,098,322
-18,669
| -0.6% | -USD 24.2 k | ﹤0.01% | 3390 |
|
|
2024
Q1 | USD 3.74 M | Compra |
3,116,991
+207,492
| +7% | +USD 208 k | ﹤0.01% | 3361 |
|
|
2023
Q4 | USD 4.39 M | Compra |
2,909,499
+736,158
| +34% | +USD 1.06 M | ﹤0.01% | 3276 |
|
|
2023
Q3 | USD 3.48 M | Venta |
2,173,341
-468,404
| -18% | -USD 853 k | ﹤0.01% | 3315 |
|
|
2023
Q2 | USD 5.73 M | Compra |
2,641,745
+237,899
| +10% | +USD 372 k | ﹤0.01% | 2991 |
|
|
2023
Q1 | USD 3.51 M | Venta |
2,403,846
-1,381,950
| -37% | -USD 1.78 M | ﹤0.01% | 3387 |
|
|
2022
Q4 | USD 4.73 M | Compra |
3,785,796
+979,242
| +35% | +USD 1.54 M | ﹤0.01% | 3214 |
|
|
2022
Q3 | USD 5.3 M | Compra |
2,806,554
+185,071
| +7% | +USD 438 k | ﹤0.01% | 3072 |
|
|
2022
Q2 | USD 6.63 M | Venta |
2,621,483
-379,928
| -13% | -USD 1.11 M | ﹤0.01% | 2870 |
|
|
2022
Q1 | USD 10.3 M | Venta |
3,001,411
-858,033
| -22% | -USD 3.03 M | ﹤0.01% | 2663 |
|
|
2021
Q4 | USD 18.6 M | Compra |
3,859,444
+1,844,799
| +92% | +USD 7.47 M | ﹤0.01% | 2173 |
|
|
2021
Q3 | USD 7.35 M | Venta |
2,014,645
-2,671,054
| -57% | -USD 9.9 M | ﹤0.01% | 3013 |
|
|
2021
Q2 | USD 19 M | Compra |
4,685,699
+1,541,480
| +49% | +USD 6.05 M | ﹤0.01% | 2091 |
|
|
2021
Q1 | USD 13.5 M | Venta |
3,144,219
-747,195
| -19% | -USD 3.57 M | ﹤0.01% | 2288 |
|
|
2020
Q4 | USD 15.4 M | Venta |
3,891,414
-1,144,446
| -23% | -USD 4.78 M | ﹤0.01% | 2075 |
|
|
2020
Q3 | USD 18.6 M | Compra |
5,035,860
+3,472,684
| +222% | +USD 14.7 M | 0.01% | 1792 |
|
|
2020
Q2 | USD 5.33 M | Compra |
1,563,176
+191,485
| +14% | +USD 429 k | ﹤0.01% | 2757 |
|
|
2020
Q1 | USD 1.84 M | Venta |
1,371,691
-850,232
| -38% | -USD 1.33 M | ﹤0.01% | 3366 |
|
|
2019
Q4 | USD 3.27 M | Compra |
2,221,923
+962,409
| +76% | +USD 1.61 M | ﹤0.01% | 3284 |
|
|
2019
Q3 | USD 2.63 M | Venta |
1,259,514
-962,914
| -43% | -USD 1.97 M | ﹤0.01% | 3349 |
|
|
2019
Q2 | USD 5.42 M | Compra |
2,222,428
+598,122
| +37% | +USD 1.3 M | ﹤0.01% | 2793 |
|
|
2019
Q1 | USD 4.24 M | Compra |
1,624,306
+128,345
| +9% | +USD 389 k | ﹤0.01% | 3103 |
|
|
2018
Q4 | USD 4.5 M | Venta |
1,495,961
-214,668
| -13% | -USD 728 k | ﹤0.01% | 2976 |
|
|
2018
Q3 | USD 5.92 M | Compra |
1,710,629
+152,251
| +10% | +USD 808 k | ﹤0.01% | 2856 |
|
|
2018
Q2 | USD 7.32 M | Venta |
1,558,378
-197,996
| -11% | -USD 751 k | ﹤0.01% | 2670 |
|
|
2018
Q1 | USD 5.57 M | Venta |
1,756,374
-80,959
| -4% | -USD 326 k | ﹤0.01% | 2805 |
|
|
2017
Q4 | USD 9 M | Venta |
1,837,333
-165,749
| -8% | -USD 962 k | ﹤0.01% | 2538 |
|
|
2017
Q3 | USD 13.7 M | Venta |
2,003,082
-72,638
| -3% | -USD 458 k | ﹤0.01% | 2295 |
|
|
2017
Q2 | USD 13.7 M | Venta |
2,075,720
-282,432
| -12% | -USD 1.98 M | ﹤0.01% | 2263 |
|
|
2017
Q1 | USD 18.9 M | Compra |
2,358,152
+561,158
| +31% | +USD 4.72 M | 0.01% | 1927 |
|
|
2016
Q4 | USD 16.7 M | Compra |
1,796,994
+680,218
| +61% | +USD 7.04 M | ﹤0.01% | 2087 |
|
|
2016
Q3 | USD 11.8 M | Venta |
1,116,776
-884,763
| -44% | -USD 8.81 M | ﹤0.01% | 2321 |
|
|
2016
Q2 | USD 18.7 M | Venta |
2,001,539
-8,054
| -0.4% | -USD 81.8 k | 0.01% | 1837 |
|
|
2016
Q1 | USD 20.9 M | Compra |
2,009,593
+869,687
| +76% | +USD 7.95 M | 0.01% | 1687 |
|
|
2015
Q4 | USD 11.5 M | Venta |
1,139,906
-64,168
| -5% | -USD 643 k | ﹤0.01% | 2148 |
|
|
2015
Q3 | USD 10.1 M | Venta |
1,204,074
-376,932
| -24% | -USD 4.99 M | ﹤0.01% | 2247 |
|
|
2015
Q2 | USD 25.4 M | Venta |
1,581,006
-2,830,140
| -64% | -USD 44 M | 0.01% | 1618 |
|
|
2015
Q1 | USD 62.5 M | Compra |
4,411,146
+1,744,588
| +65% | +USD 22.7 M | 0.02% | 928 |
|
|
2014
Q4 | USD 26.6 M | Compra |
2,666,558
+120,295
| +5% | +USD 1.03 M | 0.01% | 1617 |
|
|
2014
Q3 | USD 21.7 M | Compra |
2,546,263
+725,871
| +40% | +USD 6.38 M | 0.01% | 1731 |
|
|
2014
Q2 | USD 16.1 M | Compra |
1,820,392
+793,017
| +77% | +USD 6.92 M | 0.01% | 1970 |
|
|
2014
Q1 | USD 9.6 M | Venta |
1,027,375
-752,443
| -42% | -USD 6.6 M | ﹤0.01% | 2404 |
|
|
2013
Q4 | USD 15 M | Compra |
1,779,818
+1,698,239
| +2,082% | +USD 17.2 M | ﹤0.01% | 1994 |
|
|
2013
Q3 | USD 719 k | Venta |
81,579
-134,331
| -62% | -USD 1.08 M | ﹤0.01% | 4859 |
|
|
2013
Q2 | USD 1.53 M | Compra |
+215,910
| Nuevas | +USD 1.49 M | ﹤0.01% | 3979 |
|
Otros fondos que tienen OPK en su portafolio
Posición de Goldman Sachs en OPK: resumen de T3 2026
Goldman Sachs aumentó su participación en Opko Health (OPK) en 14% durante T3 2026, al comprar aproximadamente USD 1.41 M y elevar la posición a 8,005,331 acciones con un valor de USD 12.9 M. La posición representa ﹤0.01% del portafolio y ocupa el puesto #2989.
Goldman Sachs reportó por primera vez una posición en OPK en T2 2013 y desde entonces la ha mantenido en 54 trimestres. La posición alcanzó su máximo de USD 62.5 M en T1 2015. Al cierre de T3 2026, 226 fondos que sigue Wall St. Rank mantienen una posición en OPK.
- Al cierre de T3 2026, Goldman Sachs tenía 8,005,331 acciones de Opko Health con un valor de USD 12.9 M.
- Goldman Sachs compró 969,839 acciones de Opko Health en T3 2026, por un monto estimado de USD 1.41 M.
- Opko Health representó el ﹤0.01% del portafolio de Goldman Sachs en T3 2026 y fue su posición número 2989.
- Goldman Sachs reportó por primera vez una posición en Opko Health en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- La posición de Goldman Sachs en Opko Health alcanzó su máximo de USD 62.5 M en T1 2015.
- Al cierre de T3 2026, 226 fondos que sigue Wall St. Rank tenían Opko Health en su portafolio.
Según el informe 13F de Goldman Sachs correspondiente a T3 2026, presentado el 16 nov 2026.